CD274 and neoplasm: This indicates that SAR131675 treatment reduces the frequency of granulocytic MDSC PD-L1+ in the liver, and the frequency of both granulocytic macrophages and MDSCs compared to monocytic counterparts in the tumor and that this may play an important role in the suppression of tumor growth.